Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol HLA-G contributors: mct/npt - updated : 06-12-2019
HGNC name major histocompatibility complex, class I, G
HGNC id 4964
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • three globular extracellular domains, alpha 1 and alpha 2 forming the peptide binding groove
  • a I, C-like alpha 3 domain
  • a single transmembrane domain
  • a cytoplasmic tail
  • conjugated GlycoP
    mono polymer homomer , heteromer , monomer , dimer
    HOMOLOGY
    Homologene
    FAMILY
  • MHC class I family
  • CATEGORY antigen
    SUBCELLULAR LOCALIZATION     plasma membrane
    basic FUNCTION
  • central immune tolerance role during early pregnancy, playing an important immunoregulatory roles, including the inhibition of maternal NK and T cells and the promotion maternal tolerance of the allogeneic fetus
  • modulating cytokine production of monocyte-generated dendritic cells during early pregnancy
  • having a potential immunomodulatory role during lymphoproliferative disorders (Sebti 2007)
  • may play a crucial role for the susceptibility to Kawasaki disease (Kim 2008)
  • HLA-G homodimer, but not the monomer, induces secretion of the proinflammatory cytokines IL6 and IL8 and a small amount of TNF from both decidual macrophages and NK cells (Li 2009)
  • HLA-G, CD274 and CD276, are secreted from early and term placenta, and have important implications in the mechanisms by which trophoblast immunomodulators modify the maternal immunological environment
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS immunity/defense , reproduction/sex
    text mandatory expression for the development of pregnancy
    PATHWAY
    metabolism
    signaling
    a component
  • heterodimerizing with beta-2 microglobular
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binding for adequate complexion
  • loaded by TAP molecules
  • HLA-G ligand KIR2DL4, is mainly expressed on NK cells and CD56+ T cells with no differences between CMV+ and CMV- subjects
  • cell & other
    REGULATION
    Other transactivation regulated by CREBBP and EP300
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in lymphoproliferative disorders (Sebti 2007)
    Susceptibility to Kawasaki disease
    Variant & Polymorphism SNP nonsynonymous SNP (C/A) of the HLA-G gene (rs12722477, Leu134Ile) was significantly associated with Kawasaki disease (Kim 2008)
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS